Regulus Therapeutics Inc Lands $20,000,000 Series A Round

  • Feed Type
  • Date
    3/4/2009
  • Company Name
    Regulus Therapeutics Inc
  • Mailing Address
    1896 Rutherford Road Carlsbad, CA 92008-7208
  • Company Description
    Regulus Therapeutics, Inc., is a biopharmaceutical company created to discover, develop and commercialize microRNA-targeted therapeutics. microRNAs are small non-coding RNAs that regulate networks of genes and biological pathways through post-transcriptional mechanisms. microRNAs function by modulating levels of many target gene mRNAs and/or proteins. Modulation of mRNA targets by microRNAs finely tunes biological pathway activities and deregulated microRNA expression can profoundly affect disease pathways.
  • Website
    http://www.regulusrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Alnylam Pharmaceuticals
  • Venture Investor
    Isis Pharmaceuticals, Inc

By posting a comment, you agree to our terms and conditions.